ADT

作品数:189被引量:313H指数:8
导出分析报告
相关领域:自动化与计算机技术医药卫生更多>>
相关作者:张欣胡旭华会明李达翃李占林更多>>
相关机构:苏州大学河南大学吉林大学青岛浩澳环保科技有限公司更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家重点基础研究发展计划中国航空科学基金国家科技支撑计划更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Chinese Medical Journalx
条 记 录,以下是1-2
视图:
排序:
De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy:Network-analysis and systematic review
《Chinese Medical Journal》2025年第2期231-233,共3页Hanxu Guo Chengqi Jin Li Ding Jun Xie Jing Xu Ruiliang Wang Hong Wang Changcheng Guo Jiansheng Zhang Bo Peng Xudong Yao Jing Yuan Bin Yang 
funded by grants from the Shanghai Science Committee Foundation(No.19411967700);the National Natural Science Foundation of China(No.31570993);the Wu Jieping Medical Foundation(No.320.6750.2020-14-7).
To the Editor:In recent years,the treatment for metastatic hormone-sensitive prostate cancer(mHSPC)has undergone rapid developments.Docetaxel(DOC)or androgen receptor-targeted agent(ARTA)and androgen deprivation thera...
关键词:triplet therapy network meta analysis DOCETAXEL androgen deprivation therapy adt systemic therapiesmultiple overall survival progression free survival 
Controversies in the treatments of prostate cancer
《Chinese Medical Journal》2013年第15期2972-2977,共6页SUN Liang LU Jia-ju 
the grants from the Natural Science Foundation of Shandong Province,the Science and Technology Research Foundation of Jinan City
Prostate cancer is one of the leading causes of death in male in western countries; in addition, recently, the incidence of prostate cancer has increased rapidly in China. There are considerable variations between pra...
关键词:androgen-deprivation therapy prostate cancer maximal androgen blockade intermittent ADT castration- resistant prostate cancer surgical treatment 
检索报告 对象比较 聚类工具 使用帮助 返回顶部